Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...

Repeat infections with RSV are believed to be common ... from a targeted pathogen in a proprietary parainfluenza virus 5 vector. Clinical data have shown that administration of our intranasal ...

An American Samoa epidemiologist has extended the closure of daycare centres in the territory due to respiratory syncytial ...

Respiratory syncytial virus (RSV) is a highly contagious and ... from a targeted pathogen in a proprietary parainfluenza virus 5 vector. Clinical data have shown that administration of our ...

Variations in temperature, precipitation, and humidity can influence the spread of infectious diseases, including by altering ...

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

The deadly outbreak comes 25 years after health officials declared measles to be eliminated in the United States following an ...

Respiratory syncytial virus (RSV) is a highly contagious and common respiratory ... by expressing a protein from a targeted pathogen in a proprietary parainfluenza virus 5 vector. Clinical data have ...

So, most people who are sick right now are sick with flu, not another virus. “Initially I was optimistic it would be a good ...